AMY MIKUSA: Open Payments
NPI 1285034116 · STOW, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 11 payments from 9 companies in 2025. Trend: 2023 $88 · 2024 $79 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $48 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: MOUNJARO, REJOYN, XIFAXAN, BREZTRI, INSPIRE, VRAYLAR, Korlym, SHINGRIX.
Industry payments across OH — which companies pay providers there.
